Chapter 1 Introduction Flashcards
the practice of medicinal chemistry that is devoted to the discovery and development of new drugs
Organic Medicinal Chemistry
an AGENT intended for use in the diagnosis, mitigation, treatment, cure, or prevention of disease in humans or in other animals
DRUG
•a substance to which a drug needs to interact with to elicit a pharmacological response
•90% proteins, some are nucleic acids and lipids
RECEPTOR
•ability of drug to bind to the receptor
AFFINITY
Is Receptor a macromolecules? Yes or no and why?
Yes! 90% proteins, some are nucleic acids and lipids
•ability of a drug to exert a pharmacologic action
INTRINSIC ACTIVITY
•Affinity + Intrinsic activity
AGONIST
•Affinity only
ANTAGONIST
•site other than the binding site
ALLOSTERIC SITE
FACTORS THAT INFLUENCE THE ABSORPTION:
•Chemical structure
•Variation in particle size
•Nature of the crystal form (Amorphous > Crystalline)
–Example:
- Ultra-lente = 100% crystalline (long-acting)
- Lente insulin = 70% crystalline, 30% amorphous (intermediate)
- Semi lente = 100% amorphous (short-acting)
•Type of tablet coating
•Blood flow to the absorption site
•Total surface area available for absorption
•Contact time at the absorption surface
…
FOUR FUNDAMENTAL PATHWAYS OF DRUG PHARMACOKINETICS
Absorbtion
Distributiom
Metabolism
Excretion
the transfer of a drug from its site of administration to the systemic circulation (or to the bloodstream)
Absorption
————= 100% crystalline (long-acting)
Ultra-lente
—————= 70% crystalline, 30% amorphous (intermediate)
Lente insulin
————-= 100% amorphous (short-acting)
Semi lente
Major site of Absorption
Small intestine
Small intestine was consider major site of absorption specifically due to two parts found in small intestine which is the —— and —-
Villi and microvilli
Major site of metabolism
Liver
Major site of excretion
Kidney
Filtering unit of kidney
Nephron
Drug for prevention is called ——
Prophylaxis
•the fraction of administered drug that reaches the systemic circulation in a chemically unchanged form (f)
BIOAVAILABILITY
Bioavalability Equation
F= AUC(oral)/AUC(IV) X AUC(IV) /AUC(Oral)